Apitoria Pharma Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is SACUBITRIL-VALSARTAN PREMIX, with a corresponding US DMF Number 33622.
Remarkably, this DMF maintains an Active status since its submission on March 01, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 01, 2019, and payment made on March 01, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II